181 related articles for article (PubMed ID: 3422496)
1. Treatment of type IIa and type V hyperlipoproteinemia and of a normal volunteer by continuous LDL-apheresis.
Riesen WF; Sturzenegger E; Imhof C; Descoeudres C; Mordasini R; Oetliker OH
Prog Clin Biol Res; 1988; 255():337-46. PubMed ID: 3422496
[No Abstract] [Full Text] [Related]
2. [Effects of bezafibrate on lipoprotein lipids and apolipoproteins B and A1 in patients with primary hypercholesterolemia].
Branchi A; Sommariva D; Tirrito M; Bonfiglioli D; Pini C; Scandiani L; Orlandi S; Fasoli A
Clin Ter; 1987 Jul; 122(1):17-23. PubMed ID: 2973892
[No Abstract] [Full Text] [Related]
3. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
Hutt V; Klör HU; Wechsler JG; Ditschuneit H
J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
[TBL] [Abstract][Full Text] [Related]
4. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
Herrmann W; Reuter W
Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
[No Abstract] [Full Text] [Related]
5. Plasma exchange treatment for severe familial hypercholesterolemia: a comparison of two different techniques.
Dairou F; Rottembourg J; Truffert J; Assogba U; Bruckert E; de Gennes JL; Jacobs C
Beitr Infusionsther; 1988; 23():152-9. PubMed ID: 2484771
[No Abstract] [Full Text] [Related]
6. Selective continuous removal of low density lipoproteins by dextran sulfate cellulose column adsorption apheresis in the therapy of familial hypercholesterolemia.
Stefanutti C; Isacchi GC; Antonini R; Bucci A; Cardillo A; Di Nucci GD; Gozzer M; Malagnino F; Masci M; Mazzarella B
Beitr Infusionsther; 1988; 23():172-82. PubMed ID: 2484773
[No Abstract] [Full Text] [Related]
7. Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: prevalence and precipitating factors.
Lowry RP; Soltys G; Mangel R; Kwiterovitch P; Sniderman AD
Transplant Proc; 1987 Feb; 19(1 Pt 3):2229-32. PubMed ID: 3547921
[No Abstract] [Full Text] [Related]
8. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
[TBL] [Abstract][Full Text] [Related]
9. [Biological efficacy of LDL apheresis in major hypercholesterolemia].
Dairou F; Assogba U; Bruckert E; De Gennes JL; Turpin G
Ann Med Interne (Paris); 1994; 145(5):328-32. PubMed ID: 7985942
[TBL] [Abstract][Full Text] [Related]
10. Aggressive lipid lowering treatment in coronary atherosclerosis.
Stalenhoef AF; Kroon AA; Aengevaeren WR
Cardiologia; 1997 Sep; 42(9):935-40. PubMed ID: 9369038
[TBL] [Abstract][Full Text] [Related]
11. [Plasma exchange therapy in a patient with familial hypercholesteremia and generalized arteriosclerosis].
Schrecker O; Thies K; Schlierf G
Internist (Berl); 1984 Sep; 25(9):574-6. PubMed ID: 6386739
[No Abstract] [Full Text] [Related]
12. [Familial homozygotic infantile hypercholesterolemia treated with lipoprotein apheresis during a year].
Teruel Briones JL; Lasunción Ripa MA; Gallego Cobos N; Castañón Rodríguez MA; Ortuño Mirete J
An Esp Pediatr; 1993 Aug; 39(2):159-62. PubMed ID: 8239213
[No Abstract] [Full Text] [Related]
13. Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.
Jansen M; Banyai S; Schmaldienst S; Goldammer A; Rohac M; Hörl WH; Derfler K
Wien Klin Wochenschr; 2000 Jan; 112(2):61-9. PubMed ID: 10703153
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of apoproteins A and B, lipoproteins and plasma lipids during treatment with bezafibrate in various forms of hyperlipoproteinemia].
Saitta A; Bonaiuto M; Lanzafame F; Mileto A; Pernice F; Cinquegrani M; Mazza G; Micali G; Pangallo A; Fodale P
Clin Ter; 1988 Mar; 124(5):373-81. PubMed ID: 2974348
[No Abstract] [Full Text] [Related]
15. Evaluation of selective LDL-removal in the treatment of familial hypercholesterolemia: double membrane filtration and adsorption system.
Yamamoto A; Yokoyama S; Satani M; Kikkawa T; Kishino B
Prog Clin Biol Res; 1988; 255():357-66. PubMed ID: 3340645
[No Abstract] [Full Text] [Related]
16. From plasma-exchange to LDL-apheresis: new developments in the treatment of familial hypercholesterolemia.
Postiglione A; Gnasso A; Mastranzo P; Montefusco S; Motti C; Gallotta G; Cortese C; Scarpato N
Beitr Infusionsther; 1988; 23():74-80. PubMed ID: 2484784
[No Abstract] [Full Text] [Related]
17. Treatment of homozygous patients with familial hypercholesterolemia by double-filtration plasmapheresis.
Mabuchi H; Michishita I; Sakai T; Sakai Y; Watanabe A; Wakasugi T; Takeda R
Atherosclerosis; 1986 Aug; 61(2):135-40. PubMed ID: 3463306
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia.
Sachais BS; Katz J; Ross J; Rader DJ
J Clin Apher; 2005 Dec; 20(4):252-5. PubMed ID: 15880364
[TBL] [Abstract][Full Text] [Related]
19. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia.
Yokoyama S; Hayashi R; Satani M; Yamamoto A
Arteriosclerosis; 1985; 5(6):613-22. PubMed ID: 3865648
[TBL] [Abstract][Full Text] [Related]
20. [An apheresis method in treatment of familial hypercholesterolemia].
Derfler K
Wien Klin Wochenschr; 2000 Jan; 112(2):49-51. PubMed ID: 10703150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
